Use of Forteo (Teriparatide) in Posterolateral Lumbar Spine Fusion

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2016

Conditions

Lumbar SpondylosisLumbar SpondylolisthesisAdult Degenerative Lumbar Scoliosis

Interventions

BIOLOGICAL

teriparatide

Teriparatide 20 ug subcutaneous injection daily for 12 weeks

BIOLOGICAL

Placebo

Saline solution

Trial Locations (1)

UCSF Spine Center, San Francisco

All Listed Sponsors

collaborator

Eli Lilly and Company

INDUSTRY

lead

Shane Burch

OTHER

NCT01292252 - Use of Forteo (Teriparatide) in Posterolateral Lumbar Spine Fusion | Biotech Hunter | Biotech Hunter